PharmaEssentia Corporation (LUX:261280523)
Luxembourg
· Delayed Price · Currency is EUR · Price in USD 21.00
-1.00 (-4.55%)
At close: Mar 9, 2026
PharmaEssentia Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 5,045 | 2,966 | -623.84 | -1,375 | -2,811 | Upgrade
|
| Depreciation & Amortization | 351.55 | 336.99 | 250.58 | 225.38 | 226 | Upgrade
|
| Other Amortization | 47.05 | 30.72 | 18.18 | 2.54 | 1.09 | Upgrade
|
| Loss (Gain) From Sale of Assets | 2.03 | 0.93 | - | 0.1 | 0.07 | Upgrade
|
| Loss (Gain) on Equity Investments | 4.46 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 463.47 | 164.39 | 710.21 | 216.21 | 501.52 | Upgrade
|
| Other Operating Activities | -302.77 | -275.6 | -383.62 | -464.93 | 11.18 | Upgrade
|
| Change in Accounts Receivable | -1,849 | -1,312 | -513.66 | -332.6 | -15.45 | Upgrade
|
| Change in Inventory | -62.21 | 25.34 | -356.61 | -240.66 | -466.53 | Upgrade
|
| Change in Accounts Payable | 30.27 | -2.44 | -102.05 | 54.62 | -0.69 | Upgrade
|
| Change in Unearned Revenue | -0.23 | 0.23 | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | 1,547 | 590.17 | 291.29 | 408.68 | 91.74 | Upgrade
|
| Operating Cash Flow | 5,278 | 2,525 | -709.51 | -1,505 | -2,462 | Upgrade
|
| Operating Cash Flow Growth | 109.04% | - | - | - | - | Upgrade
|
| Capital Expenditures | -1,911 | -862 | -1,286 | -312.03 | -70.33 | Upgrade
|
| Sale (Purchase) of Intangibles | -12.51 | -41.49 | -41.65 | -8.72 | -27.54 | Upgrade
|
| Investment in Securities | -440.1 | -423.65 | -96 | - | -25 | Upgrade
|
| Other Investing Activities | -111.32 | -7.76 | 937.04 | -922.07 | 44.7 | Upgrade
|
| Investing Cash Flow | -2,475 | -1,335 | -486.65 | -1,243 | -78.18 | Upgrade
|
| Short-Term Debt Issued | 2,243 | - | 1 | 973.88 | - | Upgrade
|
| Total Debt Issued | 2,243 | - | 1 | 973.88 | - | Upgrade
|
| Short-Term Debt Repaid | -2,243 | -21 | -973.88 | - | -30 | Upgrade
|
| Long-Term Debt Repaid | -229.31 | -233.12 | -150.97 | -127.41 | -116.23 | Upgrade
|
| Total Debt Repaid | -2,472 | -254.12 | -1,125 | -127.41 | -146.23 | Upgrade
|
| Net Debt Issued (Repaid) | -229.31 | -254.12 | -1,124 | 846.47 | -146.23 | Upgrade
|
| Issuance of Common Stock | 95.55 | 91.1 | 14,330 | 8,743 | 3,045 | Upgrade
|
| Repurchase of Common Stock | - | - | -2,718 | - | -87.5 | Upgrade
|
| Common Dividends Paid | -366.17 | - | - | - | - | Upgrade
|
| Other Financing Activities | - | - | -34.56 | -10.26 | -2.41 | Upgrade
|
| Financing Cash Flow | -499.93 | -163.02 | 10,454 | 9,579 | 2,809 | Upgrade
|
| Foreign Exchange Rate Adjustments | -660.75 | 358.27 | 104.11 | 19 | -15.25 | Upgrade
|
| Net Cash Flow | 1,642 | 1,385 | 9,362 | 6,850 | 253.27 | Upgrade
|
| Free Cash Flow | 3,366 | 1,663 | -1,996 | -1,818 | -2,532 | Upgrade
|
| Free Cash Flow Growth | 102.47% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 21.53% | 17.08% | -39.09% | -63.06% | -385.74% | Upgrade
|
| Free Cash Flow Per Share | 9.07 | 4.49 | -5.58 | -5.76 | -8.77 | Upgrade
|
| Cash Interest Paid | 25.53 | 22.19 | 34.56 | 10.26 | 2.41 | Upgrade
|
| Cash Income Tax Paid | 232.89 | 297.9 | 76.87 | 5.68 | -0 | Upgrade
|
| Levered Free Cash Flow | 2,126 | 21.42 | -1,292 | -2,589 | -1,316 | Upgrade
|
| Unlevered Free Cash Flow | 2,142 | 35.29 | -1,263 | -2,577 | -1,310 | Upgrade
|
| Change in Working Capital | -333.28 | -698.22 | -681.02 | -109.97 | -390.93 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.